Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Kaskela Law LLC

< Previous 1 2 3 Next >
ZUORA LAWSUIT FILED: Investors Encouraged to Contact Kaskela Law LLC to Discuss Their Rights and Options with Respect to Proposed $10.00 Per Share Buyout
From Kaskela Law LLC
Via Business Wire
Tickers ZUO
Kaskela Law LLC Announces Shareholder Investigation of Redwire Corporation (NYSE: RDW) and Encourages Long-Term RDW Shareholders to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers RDW
Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm
From KASKELA LAW LLC
Via Business Wire
Tickers IART
Kaskela Law LLC Announces Shareholder Investigation of Blue Ridge Bankshares, Inc. (NYSE: BRBS) and Encourages Long-Term BRBS Shareholders to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers BRBS
Kaskela Law LLC Announces Shareholder Investigation of Xponential Fitness, Inc. (NYSE: XPOF) and Encourages Long-Term XPOF Shareholders to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers XPOF
Kaskela Law LLC Announces Shareholder Investigation of Driven Brands Holdings, Inc. (NASDAQ: DRVN) and Encourages Long-Term DRVN Shareholders to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers DRVN
Kaskela Law LLC Announces Shareholder Investigation of Payoneer Global Inc. (PAYO) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers PAYO
Kaskela Law LLC Announces Stockholder Investigation of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers FDMT
Kaskela Law LLC Announces Shareholder Investigation of TrueCar, Inc. (NASDAQ: TRUE) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers TRUE
Kaskela Law LLC Announces Shareholder Investigation of CBIZ, Inc. (NYSE: CBZ) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers CBZ
Kaskela Law LLC Announces Stockholder Investigation of National HealthCare Corporation (NYSE: NHC) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers NHC
Kaskela Law LLC Announces Shareholder Investigation of Tyler Technologies, Inc. (NYSE: TYL) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers TYL
Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers HOOK
Kaskela Law LLC Announces Shareholder Investigation of LegalZoom.com, Inc. (NASDAQ: LZ) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers LZ
Kaskela Law LLC Announces Shareholder Investigation of Standex International Corp. (NYSE: SXI) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers SXI
Kaskela Law LLC Announces Shareholder Investigation of Semler Scientific, Inc. (NASDAQ: SMLR) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers SMLR
Kaskela Law LLC Announces Shareholder Investigation of Builders FirstSource, Inc. (NYSE: BLDR) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers BLDR
Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers NARI
Kaskela Law LLC Announces Shareholder Investigation of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers CRVS
Kaskela Law LLC Announces Shareholder Investigation of Protalix BioTherapeutics, Inc. (NYSE: PLX) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers PLX
Kaskela Law LLC Announces Shareholder Investigation of Ocugen, Inc. (NASDAQ: OCGN) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers OCGN
Kaskela Law LLC Announces Shareholder Investigation of Kewaunee Scientific Corp. (NASDAQ: KEQU) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers KEQU
Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers FOLD
Kaskela Law LLC Announces Stockholder Investigation of AGCO Corp. (NYSE: AGCO) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers AGCO
Kaskela Law LLC Announces Shareholder Investigation of Vontier Corp. (NYSE: VNT) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers VNT
Kaskela Law LLC Announces Stockholder Investigation of Darling Ingredients Inc. (NYSE: DAR) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers DAR
Kaskela Law LLC Announces Shareholder Investigation of Halozyme Therapeutics, Inc. (HALO) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers HALO
STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Thoughtworks Holdings, Inc. (TWKS) Proposed $4.40 Per Share Buyout and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers TWKS
WOW INVESTOR NOTIFICATION: Kaskela Law LLC Announces Shareholder Investigation of WideOpenWest, Inc. (WOW) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers WOW
STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Sharecare, Inc. (SHCR) Proposed $1.43 Per Share Buyout Offer and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Tickers SHCR
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.